We performed flow cytometric characterization of CD133 [25, 26], Sox2 [30], and CD15 [22, 27, 32], three markers that have reproducibly been shown to mark TICs in a number of pediatric and adult brain tumors (Fig. 1b, Table 1). This evidence concerns the gene PROM1 and brain neoplasm.